NCT06657807

Brief Summary

Asthma is a chronic condition affecting approximately 5-15% of all Swedish children. Research has shown that asthma may be associated with increased anxiety and worry, with children who have asthma being twice as likely to experience anxiety compared to those without asthma. The coexistence of anxiety and asthma can worsen asthma symptoms and heighten anxiety, as it can be challenging to distinguish between the two conditions. Cognitive behavioral therapy (CBT) is a recommended treatment for anxiety in children, but few studies have examined the effectiveness of CBT in children with both asthma and anxiety. Our research group has previously developed internet-delivered CBT (Internet-CBT) targeting anxiety in asthma for adults, yielding promising results. Internet-CBT can significantly improve access to treatment and has been shown to be both effective and safe for other medical conditions. The primary aim of this project is to investigate whether Internet-CBT can contribute to improved quality of life, better asthma control, and reduced anxiety in children and adolescents whose asthma is complicated by their own or their parents' anxiety. We have previously developed Internet-CBT for adults with asthma and anxiety with promising outcomes. For this study, we have adapted the treatment for children, adolescents, and their parents and will evaluate its feasibility and clinical effectiveness.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable asthma

Timeline
2mo left

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Dec 2024Jul 2026

First Submitted

Initial submission to the registry

October 3, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

October 24, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

1.6 years

First QC Date

October 3, 2024

Last Update Submit

April 8, 2026

Conditions

Keywords

Internet-CBTAdolescentChildrenParents

Outcome Measures

Primary Outcomes (1)

  • PedsQL Asthma Module

    Questionnarie about asthma symptoms. Participants report how much of a problem asthma have been for them the past month on a scale ranging from 0 (never) to 5 (almost always).

    From pretreatment to 16 weeks

Secondary Outcomes (13)

  • PedsQL Quality of Life Inventory

    From pretreatment to 16 weeks

  • Asthma Control Test

    From pretreatment to 16 weeks

  • Asthma Behavior Checklist

    From pretreatment to 16 weeks

  • Fear of Asthma Symptoms Scale

    From pretreatment to 16 weeks

  • Youth Asthma Related Anxiety Scale

    From pretreatment to 16 weeks

  • +8 more secondary outcomes

Study Arms (1)

Internet-CBT

EXPERIMENTAL

Internet-CBT including 8 weekly modules

Behavioral: Online CBT

Interventions

Online CBTBEHAVIORAL

Online CBT targeting anxiety in pediatric asthma

Also known as: Internet-CBT, Internet-delivered cognitive behavior therapy
Internet-CBT

Eligibility Criteria

Age8 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 8-17 years
  • A diagnosis of asthma made by a physician and confirmed by the parents
  • Some anxiety related to asthma reported by either parent of child ("Do you feel stressed or worried about your asthma?" yes/no) and/or some restriction by asthma in daily life, which could indicate a pattern of avoidance behavior ("Do you feel hindered by your asthma in your daily life?" yes/no)

You may not qualify if:

  • Presence of severe psychiatric disorders such as severe depression or suicidal ideation.
  • Concurrent psychological treatment
  • Presence of severe somatic disorder that could interfere with participation in the CBT-treatment
  • Other respiratory disease than asthma
  • Psychotropic medication should be stable for at least 1 month before entering the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Psychiatry Research, Karolinska Institutet & Stockholm Health Care

Stockholm, Sweden

RECRUITING

MeSH Terms

Conditions

AsthmaAnxiety Disorders

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesMental Disorders

Central Study Contacts

Marianne Bonnert, PhD

CONTACT

Ulrika Ehrén, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Uncontrolled feasibility study using pretest-posttest design with 2 mo FU as primiary endpoint.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 3, 2024

First Posted

October 24, 2024

Study Start

December 1, 2024

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

April 13, 2026

Record last verified: 2026-04

Locations